# Selenium in the Treatment of Complicated Lymphatic Malformations

> **NCT01212965** · PHASE1 · TERMINATED · sponsor: **Medical College of Wisconsin** · enrollment: 5 (actual)

## Conditions studied

- Lymphatic Malformations

## Interventions

- **DRUG:** Selenium

## Key facts

- **NCT ID:** NCT01212965
- **Lead sponsor:** Medical College of Wisconsin
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-09
- **Primary completion:** 2011-09
- **Final completion:** 2012-11
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** The investigators chose to terminate the study due to participant attrition. Of the limited data evaluable, none of the patients experienced adverse events.
- **Last updated:** 2013-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01212965

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01212965, "Selenium in the Treatment of Complicated Lymphatic Malformations". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01212965. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*